| Mepha Pharma AG - Mephameson 50 mg/3 ml, Injektionslösung |
| 31890 | | 02 | | Mephameson 50 mg/3 ml | | Injektionslösung | | H02AB02 | | Dexamethasone | | 15.11.1965 | | |
|
| Composition |
| dexamethasoni natrii phosphas 50.00 mg corresp. dexamethasonum 38 mg, dinatrii edetas, propylenglycolum 450.00 mg, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium max. 4.50 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Dexamethasone Sodium Phosphate | 50mg / 3ml correspond Dexamethasone 38mg / 3ml |
| | BAG: Active Agent | Dose |
|---|
| Dexamethasone Sodium Phosphate | 50 mg |
| | | | Inactive agents | Dose |
|---|
| Dinatrii Edetas | | | Natrii Hydroxidum ad Ph | | | Propylenglycol | 450mg / 3ml |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 098 | 25 1 ampoule(s) à 3 ml | 314.37 | 358.30 | B | SL | No | | 101 | 5 1 ampoule(s) à 3 ml | 73.65 | 96.50 | B | SL | No |
|
